In:
The Analyst, Royal Society of Chemistry (RSC), Vol. 146, No. 19 ( 2021), p. 5995-6004
Abstract:
In this work, metal–organic frameworks (MOFs) are utilized as effective ECL coreactant accelerator to enhance the ECL responses of N -(aminobutyl)- N -(ethylisoluminol) (ABEI). Zn-based MOFs (MOF-Zn-1) were prepared by chelating Zn ions with melamine and thiophenedicarboxylic acid (TPDA), which observably accelerated the electrocatalytic oxidation of tripropylamine (TPA). Then, ABEI-MOF-Zn-1 as a high-performance ECL emitter was synthesized via an amide reaction between ABEI and mercaptopropionic acid (MPA) modified MOF-Zn-1. Strikingly, the ABEI-MOF-Zn-1 showed the 18-fold increase in the ECL signals relative to pure ABEI by using TPA as a coreactant. Moreover, ferrocene (Fc) as a quencher was first linked with capture DNA (cDNA), and then used to modify the ABEI-MOF-Zn-1, thereby constructing a label-free ECL biosensor. After the linkage between chloramphenicol (CAP) and aptamer DNA (aptDNA), the ECL response was definitely recovered by releasing l -DNA from double-stranded DNA (dsDNA, hybridization of aptDNA and l -DNA). The resultant sensor showed a wide linear range of 1.00 nM–0.10 mM ( R 2 = 0.99) and a low limit of detection (LOD) down to 0.11 nM for detecting CAP. This work developed a novel pattern to design an efficient ECL enhanced emitter, coupled by expanding its potential applications in clinical diagnosis.
Type of Medium:
Online Resource
ISSN:
0003-2654
,
1364-5528
Language:
English
Publisher:
Royal Society of Chemistry (RSC)
Publication Date:
2021
detail.hit.zdb_id:
1472713-4
Permalink